This page is available in multiple languages
Select Language

International Medical Device S.p.A. lists on Euronext Growth Milan


  • 13thlisting of 2023 on Euronext Growth Milan
  • International Medical Device S.p.A. brings the total number of companies listed on Euronext Growth Milan to 194
  • 30th listing on Euronext in 2023
  • Total placement volume of the offering equal to €5.97 million 

Milan – 7 July 2023 – Borsa Italiana, part of the Euronext Group, today congratulates International Medical Device S.p.A. on its listing on Euronext Growth Milan.

International Medical Device S.p.A. operates in the medtech sector, particularly in research and development, production and distribution of a wide range of X-Ray diagnostic systems. Through its three operating companies (Technix S.p.A., IMD Generators S.r.l. and Intermedical S.r.l.), the IMD Group has been active in the medical field for more than 40 years, offering highly innovative and cutting-edge solutions in terms of diagnostic imaging.

International Medical Device S.p.A. represents the thirteenth listing on Euronext Growth Milan, the market dedicated to small and medium-sized companies, the thirtieth listing on Euronext in 2023, and it brings the total number of firms currently listed on Euronext Growth Milan to 194.

In the placement phase, International Medical Device S.p.A. raised €5.42 million.

In the case of the full exercise of the over-allotment option, the total amount raised will be €5.97 million. The free float at the time of admission was 15% and the market capitalisation at IPO was €36.2 million.

Aniello Aliberti, CEO and Chairman of International Medical Device S.p.A., said: “The listing on EGM represents a milestone on the growth path that will allow us both to support the development programme by external lines, through M&A transactions, and the strengthening of our production and managerial capabilities. Our core business is oriented towards the continuous development of innovative technological solutions in the medical field aimed at the production of devices aimed at the preservation of health. Our goal, in fact, is to create value in terms of reliability and quality, positioning ourselves as a reference player capable of providing the Made In Italy efficiency and know-how that we have developed in over 40 years of activity. Confident to continue on our path with enthusiasm, we look to the future with renewed optimism, aware of achieving increasingly ambitious challenges. Special thanks to all the employees who with their constant commitment have contributed to the growth of our Group, to all the advisors who have supported us on this path of preparation for the listing, and to the investors and Dornier who have decided to put their trust in the future development project”. 


Caption Aniello Aliberti, CEO and Chairman of International Medical Device S.p.A., rang the bell during the market open ceremony this morning to celebrate the Initial Public Offering of the company.  

International Medical Device S.p.A.

I.M.D. International Medical Devices S.p.A. is the holding company of the IMD Group of the same name, which operates in the MedTech sector, specifically in the research and development, production and distribution of a wide range of X-Ray diagnostic systems. Through its three operating companies (Technix S.p.A., IMD Generators S.r.l. and Intermedical S.r.l.), IMD Group has more than 40 years of experience in the medical sector, basing its growth path on design capabilities that have enabled the development of highly innovative and cutting-edge solutions capable of capturing the trends and the highest standards of quality and safety in the industry. The business model is divided into the two areas: X-Ray Generators (through the subsidiary IMD Generators) referring to the development, production and marketing of monoblocks, RX generators and control systems (crucial components for medical equipment) and X-Ray Imaging Devices (through the subsidiaries Technix and Intermedical) referring to the development, production and marketing of the entire medical equipment (analog or digital) used in different medical fields such as, orthopedic, urological, emergency room and operating rooms.  

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter ( and LinkedIn (

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at

© 2023, Euronext N.V. - All rights reserved.